A panel of Food and Drug Administration experts is recommending the approval of a drug made by Genentech for diabetic macular edema, the company said.

A volunteer eye health and safety organization has introduced a new program that seeks to educate the public on the potential effects diabetes may have on one's vision.

Regeneron and Bayer HealthCare have initiated 1-of-2 late-stage clinical trials of their aflibercept ophthalmic solution in the treatment of a complication caused by diabetic retinopathy.

A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.

Genentech, a subsidiary of Roche, reported that its eye drug helped improve vision in patients suffering from a complication caused by diabetes.

The Food and Drug Administration declined to approve a treatment for diabetic eye disease made by Alimera Sciences, the drug maker said Dec. 23.

The prevalence of diabetic retinopathy, an eye disease caused by diabetes, has increased among diabetic...

An investigational treatment for a complication of diabetes that often leads to blindness worked better...

Latinos have higher rates of developing visual impairment, blindness, diabetic eye disease and cataracts than...

More than half the patients taking the low dose of a drug for diabetic macular...